Assignee
IMNATE SARL
LU·2 granted patents·4 pending applications·4 citations·filing 2013–2022
Top patents by PatentIndex Score
6 records- 0189US11193114B2Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccinationIMNATE SARL·Filed 2018·Granted Dec 7, 2021·4 cites·15 claims
- 0267US2021355162A1Modulation of antigen immunogenicity by deleting epitopes recognized by nkt cellsIMNATE SARL·Filed 2021·Application pending·0 cites
- 0363US2022259262A1Modulation of antigen immunogenicity by addition of epitopes recognized by nkt cellsIMNATE SARL·Filed 2022·Application pending·0 cites
- 0453US2023287083A1Cd1 peptide-epitope for use in the treatment of a disease caused by an intracellular pathogenIMNATE SARL·Filed 2021·Application pending·0 cites
- 0546US2021015897A1Methods to produce peptides, polypeptides or cells for modulating immunityIMNATE SARL·Filed 2018·Application pending·0 cites
- 0642US10087233B2Coagulation factor VIII with reduced immunogenicityIMNATE SARL·Filed 2013·Granted Oct 2, 2018·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when IMNATE SARL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →